Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03395873
Title Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Milton S. Hershey Medical Center
Indications

acute myeloid leukemia

Therapies

Avelumab + Decitabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.